P27 Analogue CP2
P27 Analogue CP2 is a macrocyclic peptide inhibitor targeting the SCFSkp2/Cks1 E3 ubiquitin ligase (Kd=32 nM) . p27 Analogue CP2 blocks SCFSkp2/Cks1-mediated ubiquitylation and degradation of p27, restoring p27 levels and inhibiting cell proliferation. p27 Analogue CP2 is promising for research of cancers dependent on Skp2 overexpression such as breast cancer[1].
Product Specifications
UNSPSC
12352209
Target
E1/E2/E3 Enzyme
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(NCC(N[C@@H](CO)C(N[C@@H](CCN1C=C(CCNC(NCCC2=CN(CCC[C@@H](C(N[C@H](C(O)=O)CCCCN)=O)NC([C@H]3N(C([C@H]([C@H](OP(O)(O)=O)C)NC([C@@H]4CCC(N)=O)=O)=O)CCC3)=O)N=N2)=O)N=N1)C(N[C@@H](CCC(O)=O)C(N4)=O)=O)=O)=O)[C@@H](N)C
Molecular Formula
C51H83N20O20P
Molecular Weight
1327.30
References & Citations
[1]Zenkevičiūtė G, et al. Development of constrained peptide inhibitors targeting an oncogenic E3 ubiquitin ligase[J]. bioRxiv, 2023: 2023.04. 27.535981.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP710090 20 µg
ErbB 4 (ERBB4) (NM_001042599) Human Recombinant Protein
Sign In for Pricing
View Details 
BNC941081-100 1x 100 µL
CD45RO (190-2F2.5), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
